Chief Executive Officer & Executive Director
Des O'Leary became Chief Executive Officer of OncoMark in July 2015. He has over 20 years’ experience in the Diagnostics industry with both early stage start-ups and international Corporations. He was Chief Operating Officer and Executive Director of Biotrin International from its establishment in the early 1990's through to its acquisition by Diasorin Corporation in 2008.